Update (16 April 2020):
We regret to announce that we have taken the difficult decision to postpone the 2020 WHO CC Summer School on Pharmaceutical Pricing and Reimbursement Policies which was scheduled to be held in Vienna at the end of July 2020.
We are very sorry for the postponement, but the decision was made with student and faculty safety in mind. Logistically, the week sees several speakers traveling from all over the globe to the summer school venue to deliver their topics, catering and accommodation need to be reliably available and the international attendees have to be able to reach Vienna. All of these aspects have become much less certain due to the COVID-19 (coronavirus) outbreak.
We are exploring the possibility of organising the School in December ’20/January ’21 or July/August ’21. Any comments are welcome. We will keep you informed of our plans on this site and our newsletter (register here).
If you have already sent an application for this year, we can assure you that we will consider your application also in the postponed version of the summer school. We will be making further announcements about the postponed Summer School during summer 2020.
Five-day training course in pharmaceutical pricing and reimbursement policies
The WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies at the Austrian Public Health Institute in Vienna together with the World Health Organization (WHO), Regional Office for Europe is offering for the fourth time a five-day training course for professionals of competent authorities and public institutions working in the field of pricing and reimbursement of medicines. International scientific experts and experienced national policy-makers will provide insights into pharmaceutical policies related to medicine pricing and reimbursement - at the time of launching new medicines, before or after the launch.
The summer school will provide lectures, hands-on training sessions, a panel discussion with distinguished experts, and case studies on implementation and optimisation of pharmaceutical policies. Study visits to relevant institutions in Austria will also be offered.
Who should attend?
The WHO CC summer school is targeted towards:
- Representatives of competent authorities in the field of pricing and reimbursement of medicines (policy makers, technical staff), and
- Payers in the health care system (e.g. health insurance institutions / sickness funds, ministries, medicines agencies, private health insurance institutions).
If justified by a strong motivation letter and supported by early registration, the organisers may also accept
- Researchers involved in policy-advice for public institutions,
- Not-for-profit stakeholders (e.g. consumer/patient organizations)
Participants from all over the globe are accepted: Given the location of the WHO Collaborating Centre and strong involvement in European networks, thematic input during the summer school will be provided to a major extent from the European perspective; however also aspects of pharmaceutical systems outside of Europe - e.g. Universal Health Coverage, Intellectual Property Rights etc. – will be covered.
Availability of places and deadlines
Limited number of places available: The Summer School accepts a maximum of 30 participants.
Deadline for application: 31 May 2020. Early application is highly recommended.